GMED Stock May Benefit Following the Acquisition of Nevro

Globus Medical, Inc. (GMED) recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the treatment of chronic pain.The latest acquisition of Nevro expands Globus Medical's presence in the musculoskeletal market. Potential Trend of GMED Stock Following the NewsSince the announcement on April 03, shares of Globus Medical have dropped 4.6%, closing at $72.02 last Thursday. On a positive note, the company is ...